U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

capmatinib [Supplementary Concept]

a c-Met inhibitor

Date introduced: February 5, 2017

PubMed search builder options

MeSH Unique ID: C000613976

Registry Number: TY34L4F9OZ

Heading Mapped to:

Entry Terms:

  • 2-fluoro-N-methyl-4-(7-(quinolin-6-yl-methyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide
  • 2-fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide
  • INC280
  • INCB28060
  • INCB-28060 free base
  • NVP-INC280
  • NVP-INC280-NX
  • INC-280
  • INCB-28060
  • CMC-583
  • capmatinib metabolite M13
  • CMC583
  • 2-fluoro-4-(7-((quinolin-6-yl)methyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzoic acid
  • CNJ-294
  • 2-fluoro-4-(7-((quinolin-6-yl)methyl)imidazo(1,2-b)-(1,2,4)triazin-2-yl)benzamide
  • capmatinib metabolite M18
  • CNJ294
  • capmatinib dihydrochloride
  • 2-fluoro-n-methyl-4-(7-(quinolin-6-ylmethyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide dihydrochloride
  • capmatinib hydrochloride anhydrous
  • capmatinib dihydrochloride monohydrate
  • capmatinib hydrochloride
  • 2-fluoro-n-methyl-4-(7-((quinolin-6-yl)methyl)imidazo(1,2- b)(1,2,4)triazin-2-yl)benzamide dihydrochloride monohydrate
  • Tabrecta

Supplemental Content

Loading ...